Key Factor Supporting Pulmonology Devices Market Development in 2025: Respiratory Disease Prevalence Drives Pulmonology Devices Market Growth

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Pulmonology Devices Market Size By 2025?
The market for pulmonary devices has seen a quick expansion in recent years. The market size is projected to rise from $1.36 billion in 2024 to $1.51 billion in 2025, representing a compound annual growth rate (CAGR) of 11.0%. The growth witnessed in the historic period can be traced back to factors such as a surge in chronic respiratory disorders, an increased emphasis on preventive healthcare, a rise in the usage of pulmonary devices, a spike in diseases requiring endoscopic ultrasound procedures, and growth in the elderly population.

How Big Is the Pulmonology Devices Market Size Expected to Grow by 2029?
The size of the pulmonology devices market is anticipated to experience robust growth in the upcoming years, with a projected value of $2.26 billion by 2029, reflecting a compound annual growth rate (CAGR) of 10.7%. This predicted increase during the forecast period can be ascribed to a rise in the occurrence of respiratory diseases, increasing levels of air pollution, an expansion in home healthcare, early diagnosis due to increased awareness, and the development of healthcare infrastructures. Forecasted trends for this period involve the incorporation of artificial intelligence, the evolution of telemedicine and remote monitoring, advances in portable and wearable devices, the application of robotic technology in less invasive diagnostic methods, and a rise in home care services.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pulmonology-devices-global-market-report

Which Key Market Drivers Powering Pulmonology Devices Market Expansion and Growth?
The increasing occurrence of respiratory conditions is projected to fuel the pulmonology devices market's expansion. These diseases, which impact the organs and tissues necessary for respiration such as the airways, lungs, and respiratory muscles, are rising due to factors such as air pollution, smoking, and job-related risks. Pulmonology devices assist in managing these respiratory ailments by providing precise diagnosis, consistent tracking, and efficient treatment with devices like spirometers, inhalers, pulse oximeters, and ventilators, thereby enhancing patient results and life quality. For example, in June 2024, the Australian Institute of Health and Welfare, a health and welfare agency based in Australia, reported that about 8.5 million Australians, or 34% of the population, suffered from chronic respiratory diseases. This figure includes approximately 2.8 million individuals, or 11% of the population, who have asthma, and 638,000 individuals, or 2.5% of the population, who have chronic obstructive pulmonary disease (COPD). As a result, the increasing incidence of respiratory illnesses is contributing to the growth of the pulmonology devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16772&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Pulmonology Devices Market?
Leading corporations in the pulmonology devices market are introducing cutting-edge products equipped with progressive technologies like the bilevel positive airway pressure (BiPAP) to augment patient convenience, enhance treatment effectiveness, and cater to a range of respiratory conditions. The BiPAP technology employs two different pressure settings for inhalation (IPAP) and exhalation (EPAP), providing a more comfortable experience for users who require continuous pressure. For example, ResMed, a US-based company that specializes in cloud-connected devices, unveiled the AirCurve 11 bilevel sleep apnea devices in February 2024. This product line of advanced BiPAP machines is created with the objective of boosting comfort and compliance for those suffering from sleep apnea and other respiratory disorders. The AirCurve 11 VAuto version offers varied pressures during exhalation, engineered to harmonize better with a patient's inherent breathing rhythm. The AirCurve 11 ASV, an adaptive servo-ventilation (ASV) device, observes 13 aspects in every breath cycle 50 times a second to maintain stable ventilation for the patient.

What Are the Emerging Segments in the Pulmonology Devices Market?
The pulmonology devices market covered in this report is segmented -

1) By Product Type: Endobronchial Ultrasound (EBUS) Needles, Pulmonary Biopsy Devices, Airway Stents, Single-Use Bronchoscopes, Other Product Types
2) By Indication: Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Tracheal And Bronchial Stenosis, Foreign Body Extraction, Other Indications
3) By End-User: Pulmonology Clinics, Hospitals, Ambulatory Surgical Centers

Subsegments:
1) By Endobronchial Ultrasound (EBUS) Needles: Radial EBUS Needles, Linear EBUS Needles, Biopsy EBUS Needles, EBUS Needles With Safety Features, EBUS Needles For Peripheral Lung Lesions
2) By Pulmonary Biopsy Devices: Core Biopsy Needles, Fine Needle Aspiration (FNA) Biopsy Devices, Vacuum-Assisted Biopsy Devices, Transthoracic Biopsy Devices, Endoscopic Pulmonary Biopsy Devices
3) By Airway Stents: Self-Expanding Airway Stents, Balloon-Expandable Airway Stents, Silicone Airway Stents, Metal Airway Stents, Hybrid Airway Stents (Silicone + Metal)
4) By Single-Use Bronchoscopes: Single-Use Flexible Bronchoscopes, Single-Use Rigid Bronchoscopes, Single-Use Pediatric Bronchoscopes, Single-Use Disposable Video Bronchoscopes, Single-Use Bronchoscopes With Integrated Suction
5) By Other Product Types: Pulmonary Function Testing Devices, Nebulizers For Pulmonary Disease Treatment, Spirometers, Pulmonary Inhalation Devices, Non-Invasive Ventilation (NIV) Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16772&type=smp

Who Are the Global Leaders in the Pulmonology Devices Market?
Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Baxter, Boston Scientific Corporation, Medline Industries LP., Olympus Corporation, Omron Healthcare, ResMed, Getinge, ICU Medical Inc., Fisher & Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG & Co. KGaA, NIOX

Which are the Top Profitable Regional Markets for the Pulmonology Devices Industry?
North America was the largest region in the pulmonology devices market in 2024. The regions covered in the pulmonology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16772

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.